Hathcock J
Council for Responsible Nutrition, Washington, DC 20036-1609, USA.
J Nutr. 2001 Mar;131(3s):1114S-7S. doi: 10.1093/jn/131.3.1114S.
Overall use of nutrient and botanical dietary supplements (DS) has increased for years across all major categories. Many DS are simply taken as part of a healthy lifestyle, but some are used to reduce risk of or modulate risk factors for specific chronic diseases, such as heart disease (vitamin E, folic acid, garlic), cancer (selenium, vitamin E, garlic) and certain birth defects (folic acid). Other DS are used for short-term benefits such as sleep management (valerian, melatonin) and enhanced physical performance (pyruvate, creatine). DS are regulated under food law, but with certain provisions that apply only to DS. Thus, DS are eligible for Food and Drug Administration (FDA)-authorized health claims under the Nutrition and Labeling Education Act (NLEA). Health claims have already been authorized for folic acid and calcium, but not for several others. In 1994, when the Dietary Supplement Health and Education Act (DSHEA) was passed, it expanded and clarified the definition of DS, specified additional requirements for safety and provided for four types of claims of nutritional support. These include prevention of classic nutritional deficiencies, structure or function (S/F) effects, mechanisms for S/F effects and general well-being. Although S/F effects result from both foods and drugs, representation that a product will treat, cure, mitigate or diagnose a disease is reserved for drugs. Therefore, the wording of S/F claims for DS has become a difficult issue in the proposed DS labeling regulations.
多年来,各类主要营养及植物性膳食补充剂(DS)的总体使用量均有所增加。许多DS仅作为健康生活方式的一部分服用,但有些则用于降低特定慢性疾病的风险或调节其风险因素,如心脏病(维生素E、叶酸、大蒜)、癌症(硒、维生素E、大蒜)以及某些出生缺陷(叶酸)。其他DS用于短期益处,如睡眠管理(缬草、褪黑素)和增强身体机能(丙酮酸、肌酸)。DS受食品法规监管,但有某些仅适用于DS的规定。因此,根据《营养与标签教育法》(NLEA),DS有资格获得美国食品药品监督管理局(FDA)批准的健康声明。叶酸和钙的健康声明已获批准,但其他几种尚未获批。1994年《膳食补充剂健康与教育法》(DSHEA)通过时,扩大并明确了DS的定义,规定了额外的安全要求,并规定了四种营养支持声明类型。这些包括预防典型营养缺乏、结构或功能(S/F)效应、S/F效应的机制以及总体健康状况。尽管S/F效应既由食物也由药物引起,但声称产品能治疗、治愈、减轻或诊断疾病的表述仅保留给药物。因此,在拟议的DS标签法规中,DS的S/F声明措辞已成为一个难题。